TORONTO (PRWEB)
June 08, 2023

Tuberculosis (TB) continues to be a global health threat, particularly affecting vulnerable populations, including children. This webinar aims to explore critical aspects of TB vaccine development.

Sample Collection:

The featured speakers will discuss how sample type is determined by analyte stability, downstream analysis and participant volume restrictions. The speakers will share insights on how microsampling can facilitate pediatric studies, contributing to improved TB vaccine evaluation and monitoring.

Biomarkers:

This webinar will delve into the current research landscape, discussing challenges and opportunities in identifying biomarkers that can guide the development and evaluation of effective TB vaccines, with particular consideration for the pediatric population.

Functional Characterization:

Explore cutting-edge methodologies and case studies to shed light on the use of flow cytometry to comprehensively analyze immune cell subsets, cytokine production and immune activation markers, aiding in the understanding of vaccine-induced immune responses and their implications for protection against TB.

Data Analysis:

The speakers will provide an overview of various computational tools and approaches used in the analysis of immunological data, enabling attendees to navigate the challenges associated with data processing, integration and interpretation.

New and Potential Future Technologies:

The webinar will explore new and future technologies that have the potential to advance TB vaccine development.

Register for this webinar on accelerating the progress in TB vaccine development with insights from microsampling, biomarkers and data analysis.

Join Professor Thomas Scriba MSc (Stell), DPhil (Oxon), Deputy Director (Immunology), South African Tuberculosis Vaccine Initiative (SATVI); and Nicholas Woudberg, PhD, Head of Scientific Strategies, Synexa Life Sciences, for the live webinar on Monday, June 26, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Accelerating TB Vaccine Development: Insights from Microsampling, Biomarkers and Data Analysis.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: